London, December 29, 2025 – Worried that hormone therapy might protect-or harm-your brain as you age? New research suggests it does neither.A comprehensive review found no evidence that treatments for menopause symptoms impact the risk of dementia.
menopause Hormone Therapy: No Impact on Dementia Risk
A large-scale study involving over a million women offers reassurance about a common concern.
- Researchers analyzed data from 10 studies encompassing over 1 million women.
- The review found no significant association between HRT and mild cognitive impairment (MCI), a precursor to dementia.
- Experts emphasize that dementia risk should not factor into decisions about starting or continuing HRT.
The findings, published in The Lancet Healthy Longevity journal, offer a data-driven viewpoint on a question that has lingered for years. For many women, the possibility of staving off cognitive decline is a hopeful consideration when weighing the pros and cons of hormone therapy. But this new evidence suggests that hope is misplaced.
A: No. This review of over a million women’s data found no significant association between hormone therapy and the risk of mild cognitive impairment, which can led to dementia. The decision to use HRT should be based on managing menopause symptoms, not on preventing cognitive decline.
The study,conducted by University college London with support from the University of Exeter,specifically examined the relationship between hormone therapy and mild cognitive impairment (MCI)-a condition characterized by problems with memory or thinking that can sometimes progress to dementia. Researchers wanted to determine if HRT offered any protective benefit or, conversely, increased the risk of cognitive decline.
“The role of menopause hormone treatment and relationship to dementia is a worry for many women,” said Professor Chris Fox from the university of Exeter Medical School. “But our state-of-the-art review indicates there is no evidence that menopause hormone treatment reduces or increases the risk of dementia. When deciding weather to take menopause hormone treatment, reducing one’s risk of dementia should not be part of that decision.”
While the research provides reassuring clarity, experts caution that further investigation is always valuable. The complex interplay between hormones, aging, and brain health warrants continued study. However,for now,the current findings reinforce existing clinical guidance: HRT should be considered for symptom management,not dementia prevention.
Understanding Mild Cognitive Impairment
MCI represents a transitional stage between normal age-related cognitive changes and more serious conditions like Alzheimer’s disease. Symptoms can include difficulty remembering recent events,trouble finding the right words,or challenges with planning and organization. Not everyone with MCI will develop dementia, but it does increase the risk.
This research doesn’t negate the importance of lifestyle factors known to support brain health, such as regular exercise, a healthy diet, and social engagement. These remain crucial for maintaining cognitive function throughout life.
